Why Xometry (XMTR) Stock is Rising Today

Author's Avatar
Oct 18, 2024

Xometry Inc. (XMTR, Financial) stock witnessed a noteworthy movement this week following the announcement of Roy Azevedo's appointment to its board of directors. As a result, the stock experienced a rise in its market performance, settling at a price of $20.37, reflecting a change of -2.07%.

Roy Azevedo, a seasoned executive with over 30 years in the aerospace and intelligence sectors, formerly served as the president of two business units at RTX. His expertise in engineering and supply chain management is expected to greatly benefit Xometry, fortifying its leadership team and enhancing its global manufacturing capabilities.

From a financial perspective, Xometry (XMTR, Financial) presents a mixed investment profile. The company's market capitalization stands at $1.004 billion, supported by a price-to-book ratio of 3.16. Despite some financial challenges, as indicated by its Altman Z-score of 1.94, which suggests mild financial stress, the Beneish M-Score of -2.42 implies that the company is unlikely to be a financial manipulator.

In terms of valuation, Xometry appears significantly undervalued, with a GF Value of $35.66. This valuation assessment suggests substantial upside potential from its current price. For detailed insights into Xometry's GF Value, you can visit the GF Value page.

Additionally, Xometry has reported a revenue growth of 18.2% over the past year, indicating a robust demand for its AI-enabled manufacturing solutions. However, recent insider selling activity, where 5,326 shares were sold, signals potential internal caution.

Investors considering Xometry should weigh these financial indicators and market dynamics carefully. While the appointment of Roy Azevedo injects fresh leadership and strategic acumen into the company, its financial metrics and market volatility should be closely monitored.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.